Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Emel Cabi Unal"'
Autor:
Melek YAMAN ORTAKOYLU, Sonay INCESOY OZDEMIR, Handan DINCASLAN, Nurdan TACYILDIZ, Emel CABI UNAL
Publikováno v:
Hematology, Transfusion and Cell Therapy, Vol 44, Iss , Pp S25- (2022)
Objective: Nivolumab is a human monoclonal antibody to programmed cell death receptor 1 (PD-1) that acts as an immune checkpoint inhibitor and is used in the immunotherapy of various types of advanced or metastatic cancer. The aim of this study is to
Externí odkaz:
https://doaj.org/article/124a2a9e536941c48182b98bcf2416ce
Autor:
Sevim Gencel Karaaslan, Gül Hatice Erkol Tuncer, Melek Yaman Ortakoylu, Sonay Incesoy Ozdemir, Handan Dincaslan, Nurdan Tacyildiz, Ömer Suat Fitoz, Koray Ceyhan, Isinsu Kuzu, Emel Cabi Unal
Publikováno v:
Hematology, Transfusion and Cell Therapy, Vol 44, Iss , Pp S44- (2022)
Case report In Langerhans cell histiocytosis thyroid involvement is rarely seen. Here, we would like to present a 12-year-old male patient with lung, external auditory canal skin and lymph node involvement in diagnosis. Disease relapse occurred with
Externí odkaz:
https://doaj.org/article/61a93f3c62a643b2a9a8dc26bd2f494f
Autor:
Melek Yaman Ortakoylu, Sonay Incesoy Ozdemir, Handan Dincaslan, Nurdan Tacyildiz, Isınsu Kuzu, Emel Cabi Unal
Publikováno v:
Hematology, Transfusion and Cell Therapy, Vol 44, Iss , Pp S42- (2022)
Case report Gastrointestinal stromal tumors (GISTs) occur exceedingly rare in children and adolescents. Eighty five percent of pediatric GISTs and 15 % of adult GISTs lack oncogenic mutations in KIT and PDGFRA. The results of tyrosine kinase inhibito
Externí odkaz:
https://doaj.org/article/7e1cdf8929e44ddfa7af0b8a726205cf
Autor:
Yilmaz, Yasin1 dryasinyilmaz@gmail.com, Dincaslan, Handan1, Ozdemir, Sonay Incesoy1, Tuncer, Gul Hatice Erkol1, Tanrioveri, Bugra1, Kutukcu, Hatice Busra1, Tacyildiz, Nurdan1, Unal, Emel Cabi1
Publikováno v:
Journal of Cancer Research & Therapeutics. Jan-Mar2024, Vol. 20, p369-374. 6p.
Publikováno v:
Clinical Trials Week; 4/15/2024, p132-132, 1p